FDA Investigating Hospitalizations Linked to Counterfeit Ozempic

WEDNESDAY, Nov 8, 2023-- The U.S. Food and Drug Administration has received at least three reports of people being hospitalized after taking counterfeit versions of the wildly popular weight-loss drugs known as semaglutides. At least one of these...